TherapeuticsMD Revenue and Competitors

Miami, FL USA



Total Funding



Estimated Revenue & Valuation

  • TherapeuticsMD's estimated annual revenue is currently $90.8M per year.(i)
  • TherapeuticsMD received $85.0M in venture funding in August 2018.
  • TherapeuticsMD's estimated revenue per employee is $946,354
  • TherapeuticsMD's total funding is $508.6M.
  • TherapeuticsMD's current valuation is $144.5M. (January 2022)

Employee Data

  • TherapeuticsMD has 96 Employees.(i)
  • TherapeuticsMD grew their employee count by -62% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. We create products to address the unique changes and challenges women experience through every stage of their lives. With momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. This includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD® brands. See our community guidelines:

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





TherapeuticsMD News

2022-04-17 - TherapeuticsMD Inc. stock falls Friday, underperforms market MarketWatch

TherapeuticsMD Inc. stock falls Friday, underperforms market MarketWatch

2022-04-13 - TherapeuticsMD Completes the Divestiture of vitaCare Prescription ... Business Wire

TherapeuticsMD Completes the Divestiture of vitaCare Prescription ... Business Wire

2019-09-03 - Can TherapeuticsMD, Inc. (TXMD) Keep Its Momentum?

Russell Angus C., Director, added 10,000 shares of TherapeuticsMD, Inc. (TXMD) to its portfolio at the rate of $2.77 per share valuing $27,700 ...

2019-09-03 - Here's Why TherapeuticsMD Jumped 34% in August

Shares of TherapeuticsMD (NASDAQ: TXMD) jumped 34% in August, according to data provided by S&P Global Market Intelligence, after the ...

2019-08-20 - TherapeuticsMD stock slides 6% after SEC charges company ...

TherapeuticsMD Inc. shares TXMD, +3.61% slid about 6% Tuesday, after the Securities and Exchange Commission charged the company with ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

TherapeuticsMD Funding

DateAmountRoundLead InvestorsReference
2013-03-18$57.5MUndisclosedJefferies LLCArticle
2015-02-12$UndisclosedUndisclosedCowen and CompanyArticle
2017-09-26$70.1MUndisclosedJ.P. MorganArticle
2018-08-01$85.0MUndisclosedGoldman Sachs & Co. LLCArticle